{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:56:24Z","timestamp":1761101784650},"reference-count":35,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2006,12,25]],"date-time":"2006-12-25T00:00:00Z","timestamp":1167004800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J of Inher Metab Disea"],"published-print":{"date-parts":[[2007,2]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:italic>Objective:<\/jats:italic> Fabry disease results from \u03b1\u2010gala\u2010 ctosidase A deficiency and is characterized by the lysosomal accumulation of globotriaosylceramide. Globotriaosylceramide storage predominantly affects endothelial cells, altering vascular wall morphology and vasomotor function. Our objective was to investigate aortic globotriaosylceramide levels, morphology and function in a mouse model of Fabry disease, and the effect of substrate reduction therapy, using the glycosphingolipid biosynthesis inhibitor <jats:italic>N<\/jats:italic>\u2010butyldeoxynojirimycin. <jats:italic>Methods and results:<\/jats:italic> Mice used were C57BL\/6J and \u03b1\u2010galactosidase A knockout (Fabry). We show progressive accumulation of aortic globotriaosylceramide throughout the lifespan of untreated Fabry mice (55\u2010fold elevation at 2 months increasing to 187\u2010fold by 19 months), localized to endothelial and vascular smooth\u2010muscle cells; there was no effect on vascular wall morphology in young Fabry mice. In old mice, storage resulted in intimal thickening. Endothelial function declined with age in Fabry mouse aorta. Aortae from <jats:italic>N<\/jats:italic>\u2010butyldeoxynojirimycin\u2010treated Fabry mice at 19 months of age had reduced endothelial globotriaosylceramide storage, fewer morphological abnormalities and less severe vasomotor dysfunction compared with untreated littermates. <jats:italic>Conclusion:<\/jats:italic> We provide evidence of a novel vascular phenotype in the Fabry mouse that has relevance to vascular disease in Fabry patients. <jats:italic>N<\/jats:italic>\u2010Butyldeoxynojirimycin treatment partially prevented the phenotype in the Fabry mouse by reducing endothelial globotriaosylceramide storage.<\/jats:p>","DOI":"10.1007\/s10545-006-0473-y","type":"journal-article","created":{"date-parts":[[2006,12,25]],"date-time":"2006-12-25T04:34:17Z","timestamp":1167021257000},"page":"79-87","source":"Crossref","is-referenced-by-count":31,"title":["Severe endothelial dysfunction in the aorta of a mouse model of Fabry disease; partial prevention by <i>N<\/i>\u2010butyldeoxynojirimycin treatment"],"prefix":"10.1002","volume":"30","author":[{"given":"T.","family":"Heare","sequence":"first","affiliation":[{"name":"Glycobiology Institute, Department of Biochemistry University of Oxford Oxford UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. J.","family":"Alp","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine University of Oxford, John Radcliffe Hospital Oxford UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. A.","family":"Priestman","sequence":"additional","affiliation":[{"name":"Glycobiology Institute, Department of Biochemistry University of Oxford Oxford UK"},{"name":"Department of Pharmacology University of Oxford Oxford UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. B.","family":"Kulkarni","sequence":"additional","affiliation":[{"name":"Functional Genomics Unit, National Institute of Dental and Craniofacial Research National Institutes of Health Bethesda Maryland USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Qasba","sequence":"additional","affiliation":[{"name":"Blood Diseases Program National Heart Lung and Blood Institute Bethesda Maryland USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. D.","family":"Butters","sequence":"additional","affiliation":[{"name":"Glycobiology Institute, Department of Biochemistry University of Oxford Oxford UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. A.","family":"Dwek","sequence":"additional","affiliation":[{"name":"Glycobiology Institute, Department of Biochemistry University of Oxford Oxford UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Clarke","sequence":"additional","affiliation":[{"name":"Burdon Sanderson Cardiac Science Centre University Laboratory of Physiology, University of Oxford Oxford UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. M.","family":"Channon","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine University of Oxford, John Radcliffe Hospital Oxford UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. M.","family":"Platt","sequence":"additional","affiliation":[{"name":"Glycobiology Institute, Department of Biochemistry University of Oxford Oxford UK"},{"name":"Department of Pharmacology University of Oxford Oxford UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,12,25]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI9711"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.32.7.1559"},{"key":"e_1_2_1_4_1","first-page":"280","article-title":"Fabrazyme\u2014recombinant protein treatment for Fabry's disease","volume":"95","author":"Barngrover D","year":"2002","journal-title":"J Biotechnol"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000154550.15963.80"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.38.9.629"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.med.57.110104.115650"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1012451320105"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.60.5.955"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.83.3.1057"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02161-9"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(200002)47:2<229::AID-ANA13>3.0.CO;2-T"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.2002.tb03112.x"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1006\/rwgn.2001.0443"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000043901.45141.D4"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2275(20)30162-0"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.90.1.35"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.92.12.3424"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000012748.58444.08"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.2001.00669.x"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.11.6388"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410400105"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1161\/hc3801.096352"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2261-2-1"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.6.2540"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.11.6423"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199503000-00008"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s001250050767"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(17)37202-2"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.276.5311.428"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.31.19365"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(00)00892-5"},{"key":"e_1_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119131"},{"key":"e_1_2_1_34_1","doi-asserted-by":"publisher","DOI":"10.1006\/abio.2001.5393"},{"key":"e_1_2_1_35_1","first-page":"177","article-title":"Angiokeratoma corporis diffusum: a clinical study of eight affected families","volume":"31","author":"Wise D","year":"1962","journal-title":"Q J Med"},{"key":"e_1_2_1_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-9822(01)00396-7"}],"container-title":["Journal of Inherited Metabolic Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1007\/s10545-006-0473-y","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1007\/s10545-006-0473-y","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1007\/s10545-006-0473-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T04:07:05Z","timestamp":1694750825000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1007\/s10545-006-0473-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12,25]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["10.1007\/s10545-006-0473-y"],"URL":"https:\/\/doi.org\/10.1007\/s10545-006-0473-y","archive":["Portico"],"relation":{},"ISSN":["0141-8955","1573-2665"],"issn-type":[{"value":"0141-8955","type":"print"},{"value":"1573-2665","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,12,25]]}}}